LIVZON PHARMAC. GRP H YC1 financial statements, including revenue, expenses, profit, and loss

The total revenue of LP6 for the last quarter is 413.55 M EUR, and it's 20.43% higher compared to the previous quarter. The net income of Q1 24 is 78.29 M EUR.